MARINUS is a leader in the development of neurosteroids for the treatment of depression. It is developing ganaxolone for PPD (Postpartum Depression). Topline data from a Phase 2 study should be available in H2. The stock price dropped after its Q earnings results. Its cash of $21.47M is solid to fund its operations and this is good for me. Technically the recent...
MRNS is going to move above up. It will touch 8 soon and may break up to 9 in long term. I think its a risk worth to take. Current price is 7.08. Watch this one out.
Impatto sulla media 200gg ed ipervenduto. Tenterei un ingresso lunedì su tenuta dei prezzi per una reazione da questi livelli.
Early reversal possibility after an upswing, RSI losing momentum
MRNS is following a general uptrend (and has been since the beginning of the year), while holding below a previous level of strong resistance (temporarily broken in September of last year). Today's decrease of about 4% was on low volume as opposed to previous days where the selling was more substantial. RSI is just below 50 which is about as low as it's dropped...
possible breakout 1.4 or returning to 0.95 support.
MRNS is making higher lows after the previous drop. Pay attention to the level posted on chart just in case of breakout, there is a big gap to fill. A strong breakdown under the rising trendline invalidates this setup.
great formation with first target at 2 stop 1.59 and entry 1.71
consolidation for the next leg up, break of $2.63 will test $3.
A great pattern to follow the next days, I like to let this position run in the long term